Page last updated: 2024-12-06
3-amino-1-phenylbutane
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
3-amino-1-phenylbutane: urinary metabolite of labetalol; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 31160 |
| SCHEMBL ID | 1280 |
| MeSH ID | M0162115 |
Synonyms (66)
| Synonym |
|---|
| nsc 115524 |
| benzenepropanamine, alpha-methyl- |
| 1-phenyl-3-amino-butan [german] |
| brn 2413110 |
| propylamine, alpha-methyl-gamma-phenyl- |
| einecs 244-942-2 |
| alpha-methyl-gamma-phenyl-n-propylamin [german] |
| alpha-methyl-gamma-phenyl-n-propylamine |
| alpha-methylbenzenepropanamine |
| 4-phenyl-2-aminobutane |
| nsc115524 |
| .alpha.-methylbenzenepropanamine |
| benzenepropanamine, .alpha.-methyl- |
| nsc-115524 |
| 1-methyl-3-phenylpropylamine |
| propylamine, 1-methyl-3-phenyl- |
| 1-phenyl-3-aminobutane |
| 3-amino-1-phenylbutane |
| 22374-89-6 |
| 1-methyl-3-phenylpropylamine, 98% |
| 4-phenyl-2-butylamine |
| A0999 |
| 22148-77-2 |
| wecuigdewbnqjj-uhfffaoysa- |
| inchi=1/c10h15n/c1-9(11)7-8-10-5-3-2-4-6-10/h2-6,9h,7-8,11h2,1h3 |
| 4-phenylbutan-2-amine |
| AKOS000119752 |
| 2-amino-4-phenylbutane |
| A815973 |
| [(1s)-1-methyl-3-phenyl-propyl]ammonium |
| A816167 |
| unii-326655w66z |
| alpha-methyl-gamma-phenyl-n-propylamin |
| 1-phenyl-3-amino-butan |
| 326655w66z , |
| FT-0608062 |
| FT-0605036 |
| FT-0605241 |
| FT-0604461 |
| PS-5334 |
| 1-methy-3-phenylpropylamine |
| 1-phenyl-3-butylamine |
| 1-methyl-3-phenyl-propylamine |
| 1-methyl 3-phenyl-propylamine |
| AKOS016051338 |
| SCHEMBL1280 |
| W-107477 |
| 3-phenyl-1-methylpropylamine |
| propylamine, .alpha.-methyl-.gamma.-phenyl- |
| .alpha.-methyl-.gamma.-phenyl-n-propylamine |
| 4-phenyl-2-butanamine |
| (3-aminobutyl)benzene |
| F2190-0401 |
| mfcd00008090 |
| AC-8354 |
| (r)-alpha-methylbenzenepropanamine |
| DTXSID60871334 |
| STL193993 |
| AMY40882 |
| Q27256149 |
| benzenepropanamine, -methyl- |
| SB47247 |
| methyl-(3-phenylpropyl)- |
| CS-0022291 |
| EN300-20027 |
| Z104476462 |
Research Excerpts
Pharmacokinetics
| Excerpt | Reference | Relevance |
|---|---|---|
| " Pharmacokinetic analysis shows the apparent elimination half-life of the metabolite to be 13." | ( Disposition, metabolism, and pharmacodynamics of labetalol in adult sheep. Abbott, FS; Axelson, JE; Doroudian, A; Hall, C; Kwan, E; Rurak, DW; Yeleswaram, K, ) | 0.13 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (3)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 25.19
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.19) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 1 (20.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||